The RESP® Biosensor

A next-generation wearable system for real-world respiratory monitoring

FDA 510(k) Cleared | CE Mark | HIPAA Compliant

Respiratory Monitoring Device: the RESP Biosensor

From Stethoscope to Sensor

Traditional stethoscope auscultation has been a gold standard for assessing respiratory health for over 200 years, with lung sounds such as cough, wheeze, rhonchi, or crackles indicating blockage and other problems in the airways. However, it is limited to episodic, in-person visits.

As we developed a solution to improve the management of chronic respiratory diseases, we designed the RESP® Biosensor to continuously capture lung sounds, extending the reach of stethoscope auscultation and providing clinical and research teams with insight into respiratory health anytime, anywhere.

Clients & Partners

Technology Overview

The RESP® Biosensor, often described as the ‘Holter monitor for the lungs’, is designed to continuously capture high-fidelity cough, lung sounds, and physiological measures to provide greater insight into respiratory status from anywhere, anytime.

Clinically validated with equivalent performance to standard electronic stethoscopes¹
Patient-friendly technology that’s wireless, discreet and privacy-preserving
Comprehensive reports prepared by Strados Labs team

1. M. Glass, et al. Results of Clinical Performance Testing of a Novel Wearable e-Stethoscope in Patients with Chronic Lung Diseases [abstract]. Am J Respir Crit Care Med

RESP® Biosensor Measures

Onboard inertial measurement unit (IMU) allows for physiological insights alongside cough and lung sounds

- - - - Cough Frequency (24-hour)
      - Cough Intensity* & Bouts
      - Wheeze
      - Rhonchi
      - Crackles
      - Breathing Patterns & Respiratory Rate*
      - Heart Rate & Heart Rate Variability*
      - Orientation*
      - Sleep/Wake*
      - Activity Levels*

*Measurement not FDA cleared but may be collected in clinical trials

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Applications

Disease Surveillance

Clinical Trial Endpoints

Academic Research

Addressing a Gap in Standard of Care

While pulmonary function tests, episodic auscultation, and patient-reported outcomes remain standard of care in respiratory care and research, RESP® addresses key limitations of each approach.